Viewing Study NCT00450892


Ignite Creation Date: 2025-12-24 @ 3:36 PM
Ignite Modification Date: 2026-01-01 @ 2:14 PM
Study NCT ID: NCT00450892
Status: COMPLETED
Last Update Posted: 2016-07-07
First Post: 2007-03-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module